|
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar Gel for Treatment of Infantile Spa
(GlobeNewswire via COMTEX News Network) -- Questcor Pharmaceuticals, Inc.(Nasdaq:QCOR) announced that it has resubmitted to the U.S. Food & Drug Administration (FDA) its supplemental New Drug Application (sNDA) seeking approval...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(r) Gel for Treatment of Infantile
(GlobeNewswire via COMTEX) -- QCOR | Quote | Chart | News | PowerRating -- Questcor Pharmaceuticals, Inc.(Nasdaq:QCOR) announced that it has resubmitted to the U.S. Food & Drug Administration (FDA) its supplemental New Drug...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(r) Gel for Treatment of Infantile
UNION CITY, Calif., Dec.2, 2008 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (NasdaqCM:QCOR - News) announced that it has resubmitted to the U.S. Food & Drug Administration (FDA) its supplemental New Drug Application (sNDA)...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(r) Gel for Treatment of Infantile
(GlobeNewswire via COMTEX) -- Questcor Pharmaceuticals, Inc.(QCOR:QCORNews, chart, profile, moreLast: Delayed quote dataAnalyst Create alertInsider Discuss Financials Sponsored by:, , ) announced that it has resubmitted to the U.S. Food...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(r) Gel for Treatment of Infantile
UNION CITY, Calif., Dec.2, 2008 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced that it has resubmitted to the U.S. Food & Drug Administration (FDA) its supplemental New Drug Application (sNDA) seeking...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(r) Gel for Treatment of Infantile
UNION CITY, Calif., Dec.2, 2008 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced that it has resubmitted to the U.S. Food & Drug Administration (FDA) its supplemental New Drug Application (sNDA) seeking...
|
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for
In June 2006 Questcor submitted a sNDA to the FDA and in May 2007 the FDA determined the sNDA was not approvable in the form submitted in 2006.Subsequently, Questcor met with the FDA to review the company's plans for resubmission. 'We...
|
|
|
Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model
/PRNewswire/ -- Cytochroma today announced positive comparative data on a novel vitamin D analog, CTA018, at the 2008 Annual Meeting of the American Society of Nephrology (ASN) in Philadelphia.In preclinical models, CTA018 has...
|
